Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 3 | 5 |
| 1.1 List of Tables | 6 | 1 |
| 1.2 List of Figures | 7 | 1 |
| 2 Introduction | 8 | 1 |
| 2.1 GBI Research Guidance | 8 | 1 |
| 3 Global Home Healthcare Equipment Overview | 9 | 1 |
| 4 Global Home Healthcare Equipment: Market Characterization | 10 | 12 |
| 4.1 Global Home Healthcare Equipment Market, Revenues ($m), 2002 2009 | 10 | 1 |
| 4.2 Global Home Healthcare Equipment Market, Revenue Forecasts ($m), 2009 2016 | 11 | 1 |
| 4.3 Global Home Healthcare Equipment Market, Key Company Shares (%), 2008 | 12 | 1 |
| Global Home Healthcare Equipments, Key Market Trends | 13 | 1 |
| 4.4.1 Entry of Telecom and IT Companies in Telemedicine to boost Remote Patient Monitoring | 13 | 1 |
| 4.4.2 Most Countries Working Towards Phasing Out Of CFC Containing Inhalers | 14 | 1 |
| 4.5 Global Home Healthcare Devices: Key Technology Trends | 14 | 1 |
| 4.5.1 Innovations to Target Expediency Driven Consumers for Home Monitoring | 14 | 1 |
| 4.5.2 Technological Advancements Which Improve Performance of Home Monitoring Devices | 15 | 1 |
| 4.5.3 Wireless Revolution in Home Patient Monitoring | 15 | 2 |
| 4.6 Global Home Healthcare Equipment, Market Drivers | 17 | 1 |
| 4.6.1 Economic Market Drivers | 17 | 1 |
| 4.6.1.1 Rising Healthcare Expenditure in Developed Nations as Percentage of GDP is Forcing Healthcare Payers to look for Alternatives | 17 | 1 |
| 4.6.1.2 Reimbursement Reforms Which Reward Clinical Outcomes to Increase Adoption by Providers | 18 | 1 |
| 4.6.1.3 Increasing Affordability of Home Healthcare Equipment through Availability of Reimbursement, Flexible Payment Options and Declining Costs to Drive Adoption among Patients and Providers | 18 | 1 |
| 4.6.2 Technology Drivers | 19 | 1 |
| 4.6.2.1 Technological Advancements to Improve Performance and Ease-Of-Use of Current Devices to Drive the Home Healthcare Equipment Market | 19 | 1 |
| Social Drivers | 20 | 1 |
| 4.6.3.1 Home Healthcare Equipment Market Driven To Be Driven By Rising Incidence Of Chronic Conditions Along With Aging Population Across the Globe | 20 | 1 |
| 4.7 Global Home Health Monitoring, Market Restraints | 21 | 1 |
| 4.7.1 Economic Market Restraints | 21 | 1 |
| 4.7.1.1 Affordability in Developing Nations Deterring Market Growth | 21 | 1 |
| 4.7.1.2 Unavailability of Direct Reimbursement for Some Home Health Monitoring Devices Restraining Adoption | 21 | 1 |
| 4.7.2 Technology Restraints | 21 | 1 |
| 4.7.2.1 Security and Privacy Issues Hamper Adoption of Remote Patient Monitoring | 21 | 1 |
| Global Home Healthcare Equipment: Market Category Analysis and Forecasts | 22 | 30 |
| 5.1 Glucose Monitoring Devices: Market Characterization | 22 | 1 |
| 5.1.1 Global Glucose Monitoring Devices Market, Revenues ($m), 2002 2009 | 22 | 1 |
| 5.1.2 Global Glucose Monitoring Devices Market, Revenue Forecasts ($m), 2009 2016 | 23 | 1 |
| 5.1.3 Global Glucose Monitoring Devices Market, Key Company Shares (%), 2008 | 24 | 1 |
| 5.1.4 Glucose Monitoring Market: Market Drivers | 25 | 1 |
| 5.1.4.1 Growing Diabetic Population and Increased Awareness and Evidence of the Benefits of Regular Glucose Monitoring To Drive Glucose Monitoring Market | 25 | 1 |
| 5.1.4.2 Falling Prices an Important Driver in Improving Patients Affordability | 26 | 1 |
| 5.1.4.3 Improved Technology To Lead to more Adoption in Self Monitoring | 26 | 1 |
| 5.1.5 Glucose Monitoring Market: Market Restraints | 26 | 1 |
| 5.1.5.1 Non Compliance Due To High Costs to Deter Market Growth in Short Term | 26 | 1 |
| Aversion to Pricking Fingers | 27 | 1 |
| 5.1.5.3 Unequal Distribution of Expenditure on Treatment and Prevention of Diabetes To Lead to Slow Adoption Across Developing Nations | 27 | 1 |
| 5.1.5.4 Lack of Reimbursement for Continuous Blood Glucose Monitors to Hinder Their Uptake | 27 | 1 |
| 5.2 Insulin Delivery Market: Market Characterization | 28 | 1 |
| 5.2.1 Global Insulin Delivery Market, Revenues ($m), 2002 2009 | 28 | 1 |
| 5.2.2 Global Insulin Delivery Market, Revenue Forecasts ($m), 2009 2016 | 29 | 1 |
| 5.2.3 Global Insulin Delivery Market, Key Company Shares (%), 2008 | 30 | 1 |
| Insulin Delivery Market: Market Drivers | 31 | 1 |
| 5.2.4.1 Growing Incidence of Type 1 Diabetes across the World to Sustain Demand for Insulin Delivery Systems | 31 | 1 |
| 5.2.4.2 New Technologies for Eliminating Use of Needles to Increase Compliance | 32 | 1 |
| 5.2.4.3 Closed Loop Insulin Delivery System to See Rising Adoption among Young Patients | 32 | 1 |
| 5.2.5 Insulin Delivery Market: Market Restraints | 32 | 1 |
| 5.2.5.1 High costs Limit Insulin Pumps Adoption | 32 | 1 |
| 5.2.5.2 High risk of infections among others Deter Market Growth for Insulin Pumps | 33 | 1 |
| 5.3 Inhalation Systems Market: Market Characterization | 33 | 1 |
| 5.3.1 Global Inhalation Systems Market, Revenues ($m), 2002 2009 | 33 | 1 |
| 5.3.2 Global Inhalation Systems Market, Revenue Forecasts ($m), 2009 2016 | 34 | 1 |
| Global Inhalation Systems Market, Key Company Shares (%), 2008 | 35 | 1 |
| 5.3.4 Inhalation Systems Market: Market Drivers | 35 | 1 |
| 5.3.4.1 Rising Incidence of Respiratory Diseases to Drive Market | 35 | 1 |
| 5.3.4.2 Expansion of Indications for Inhalation Systems beyond Asthma and COPD to widen patient base | 36 | 1 |
| 5.3.5 Inhalation Systems Market: Market Restraints | 36 | 1 |
| 5.3.5.1 Ineffective drug delivery and dosing inconsistency to hinder widespread market acceptance | 36 | 1 |
| 5.4 Hearing Aids Market: Market Characterization | 37 | 1 |
| 5.4.1 Global Hearing Aids Market, Revenue ($m), 2002 2009 | 37 | 1 |
| 5.4.2 Global Hearing Aids Market, Revenue Forecasts ($m), 2009 2016 | 38 | 1 |
| 5.4.3 Global Hearing Aids Market, Key Company Shares (%), 2008 | 39 | 1 |
| Hearing Aids Market: Market Drivers | 40 | 1 |
| 5.4.4.1 Technology Innovations for Improving Sound Quality to Drive Sales of Digital Hearing Aids | 40 | 1 |
| 5.4.4.2 Market for hearing devices is driven by demand for hearing instruments that are less visible and incorporate advanced technologies. | 40 | 1 |
| 5.4.4.3 Aging Population Will Drive Volumes of Ear, Nose and Throat Devices Such As Hearing Aids | 40 | 1 |
| 5.4.5 Hearing Aids Market: Market Restraints | 40 | 1 |
| 5.4.5.1 Lack of Reimbursement for Some Hearing Aids Hamper Growth | 40 | 1 |
| 5.5 Automatic Sphygmomanometer Market: Market Characterization | 41 | 1 |
| 5.5.1 Global Automatic Sphygmomanometer Market, Revenues ($m), 2002 2009 | 41 | 1 |
| 5.5.2 Global Automatic Sphygmomanometer Market, Revenue Forecasts ($m), 2009 2016 | 42 | 1 |
| 5.5.3 Global Automatic Sphygmomanometer Market, Key Company Shares (%), 2008 | 43 | 1 |
| Global Automatic Sphygmomanometer Market: Market Drivers | 44 | 1 |
| 5.5.4.1 Growing Number of People with Hypertension in both Developed and Developing Nations a Major Growth Driver | 44 | 1 |
| 5.5.4.2 Developing Nations to Drive Future Markets as Uptake Rises with Awareness and Spending Power | 44 | 1 |
| 5.5.4.3 Escalating Costs Associated With Hypertension Are Driving Home Monitoring For Blood Pressure | 44 | 1 |
| 5.5.4.4 Large number of favorable clinical studies to drive adoption of home monitoring | 44 | 1 |
| 5.5.4.5 Technical Advancements for Ease-Of-Use Promoting Rapid Adoption | 44 | 1 |
| 5.5.5 Global Market Restraints Automatic Sphygmomanometer Market: Market Restraints | 45 | 1 |
| 5.5.5.1 Insurance Companies Slow To Cover Blood Pressure Monitors for Home Use | 45 | 1 |
| 5.5.5.2 Local Competition Erode Prices and Affects the Company Bottom-Line | 45 | 1 |
| 5.5.5.3 Lack of Clear Guidelines and Reluctance by Physicians to Endorse Home Monitoring Of Blood Pressure | 45 | 1 |
| 5.6 Remote Monitoring Market: Market Characterization | 46 | 1 |
| 5.6.1 Global Remote Monitoring Market, Revenues ($m), 2002 2009 | 46 | 1 |
| 5.6.2 Global Remote Monitoring Market, Revenue Forecasts ($m), 2009 2016 | 47 | 1 |
| 5.6.3 Global Remote Monitoring Market, Key Company Shares (%), 2008 | 48 | 1 |
| 5.6.4 Global Remote Monitoring Market: Market Drivers | 48 | 1 |
| 5.6.4.1 Emphasis on Cost Control and Decreasing Medical Errors Along With Improved Quality of Care, Is Driving Adoption of Remote Patient Monitoring | 48 | 1 |
| 5.6.4.2 Greater Involvement in Disease to Increase Acceptance of Remote Patient Monitoring Among Patients and Patient Compliance | 49 | 1 |
| 5.6.4.3 Advanced Easy-To-Use Technology Solutions Spur Uptake for Remote Patient Monitoring | 49 | 1 |
| 5.6.4.4 Shortage of Skilled Personnel is Pushing Healthcare Providers towards Remote Monitoring | 50 | 1 |
| 5.6.5 Global Remote Monitoring Market: Market Restraints | 50 | 1 |
| 5.6.5.1 High Cost and Lack of Reimbursement Prevents Mass Adoption by Patients | 50 | 1 |
| 5.6.5.2 Insufficient Incentives for Technology Adoption and Wariness on Part of the Healthcare Providers Slows Acceptance | 50 | 1 |
| 5.6.5.3 Lack of substantial clinical evidence a major restraint | 51 | 1 |
| 6 Global Home Healthcare Equipment: Strategic Competitive Assessment | 52 | 7 |
| 6.1 Key Market Participants | 52 | 1 |
| 6.1.1 F. Hoffmann-La Roche Ltd | 52 | 1 |
| 6.1.1.1 Company Overview | 52 | 1 |
| 6.1.1.2 Pipeline Product Portfolio | 53 | 1 |
| 6.1.2 AstraZeneca | 53 | 1 |
| 6.1.2.1 Company Overview | 53 | 1 |
| 6.1.3 LifeScan | 53 | 1 |
| 6.1.3.1 Company Overview | 53 | 1 |
| 6.1.4 Abbott Laboratories | 54 | 1 |
| 6.1.4.1 Company Overview | 54 | 1 |
| 6.1.5 GlaxoSmithKline | 55 | 1 |
| 6.1.5.1 Company Overview | 55 | 1 |
| 6.1.6 Medtronic | 55 | 1 |
| 6.1.6.1 Company Overview | 55 | 1 |
| 6.1.6.2 Pipeline Product Portfolio | 56 | 1 |
| 6.1.7 Becton, Dickinson and Company | 57 | 1 |
| 6.1.7.1 Company Overview | 57 | 1 |
| 6.1.8 Boehringer Ingelheim | 57 | 1 |
| 6.1.8.1 Company Overview | 57 | 1 |
| 6.1.8.2 Pipeline Product Portfolio | 58 | 1 |
| Global Home Healthcare Equipment: Product Pipeline Analysis | 59 | 15 |
| 7.1 Pipeline Products by Category | 59 | 1 |
| 7.1.1 Pipeline Products By Segment: Glucose Monitoring | 60 | 1 |
| 7.1.2 Pipeline Products By Segment: Insulin Delivery | 61 | 1 |
| 7.2 List of Pipeline Products | 62 | 6 |
| Key Pipeline Products | 68 | 1 |
| 7.3.1 Glucose Monitoring | 68 | 1 |
| 7.3.1.1 GlucoTrack | 68 | 1 |
| 7.3.1.2 SensoCard Plus meter | 68 | 1 |
| 7.3.1.3 ACCU-Chek Inform II with RALS Plus Data Management System | 68 | 1 |
| 7.3.1.4 Breath-Based Blood Glucose Monitor | 68 | 1 |
| 7.3.1.5 GluCath Intravascular Continuous Glucose Monitor | 68 | 1 |
| Glucoband | 69 | 1 |
| 7.3.1.7 Symphony tCGM System-Home | 69 | 1 |
| 7.3.2 Insulin Delivery | 69 | 1 |
| 7.3.2.1 Artificial Pancreas - Closed Loop System | 69 | 1 |
| 7.3.2.2 Paradigm Veo System | 69 | 1 |
| 7.3.2.3 Intranasal Insulin Delivery Device | 69 | 1 |
| 7.3.2.4 InsuPatch Device | 69 | 1 |
| 7.3.2.5 ProMaxx Insulin Delivery System | 70 | 1 |
| 7.3.2.6 Transdermal Basal Insulin Patch | 70 | 1 |
| 7.3.3 Inhalation Systems | 70 | 1 |
| 7.3.3.1 Acu-Breathe Dry Powder Inhalers 15-Dose | 70 | 1 |
| 7.3.3.2 GelVac Intranasal Powder Vaccine Delivery System | 70 | 1 |
| 7.3.3.3 NanoGent Inhaler | 71 | 1 |
| 7.3.3.4 Nektar Pulmonary Inhaler | 71 | 1 |
| 7.3.4 Hearing Aid Devices | 71 | 1 |
| 7.3.4.1 Cochlear Hybrid System | 71 | 1 |
| 7.3.4.2 Esteem | 71 | 1 |
| 7.3.4.3 Hearing Aid by Audiodent Israel, Ltd. | 71 | 1 |
| 7.3.4.4 SoundBite Hearing System | 72 | 1 |
| 7.3.5 Automatic Sphygmomanometer | 72 | 1 |
| 7.3.5.1 HEM-SOLAR Automatic Upper-Arm Blood Pressure Monitor | 72 | 1 |
| 7.3.5.2 Wearable Blood Pressure Monitor | 72 | 1 |
| 7.3.6 Remote Patient Monitoring | 72 | 1 |
| 7.3.6.1 WristClinic | 72 | 1 |
| 7.3.6.2 Next Generation LifeShirt System | 72 | 1 |
| 7.3.6.3 MDKeeper | 73 | 1 |
| Global Home Healthcare Equipment Market: Consolidation Landscape | 74 | 6 |
| 8.1 Deals by Type, 2006 2009 | 74 | 1 |
| 8.2 Deals by Value and Volume, 2006 2009 | 75 | 1 |
| 8.3 Key Mergers and Acquisitions, 2006 2009 | 75 | 1 |
| 8.3.1 Dainippon Sumitomo Pharma Completes Acquisition of Sepracor for $2.6 Billion | 75 | 1 |
| 8.3.1.1 Deal Rationale | 76 | 1 |
| 8.3.2 3M Acquires Aearo Technologies From Permira | 76 | 1 |
| 8.3.2.1 Deal Rationale | 76 | 1 |
| 8.3.3 Technitrol Acquires Sonion | 76 | 1 |
| 8.3.3.1 Deal Rationale | 76 | 1 |
| 8.3.4 Sonova Holding Completes Acquisition Of InSound Medical | 76 | 1 |
| 8.3.4.1 Deal Rationale | 76 | 1 |
| 8.3.5 Bayer HealthCare Diabetes Care Acquires Metrika | 77 | 1 |
| 8.3.5.1 Deal Rationale | 77 | 1 |
| 8.3.6 Ypsomed Holding Acquires 10% Equity Stake in BIONIME | 77 | 1 |
| 8.3.6.1 Deal Rationale | 77 | 1 |
| 8.3.7 Derwood Chase and Michael Stewart Acquires Zounds | 77 | 1 |
| 8.3.7.1 Deal Rationale | 77 | 1 |
| 8.3.8 Mediscience Technology Acquires SensiVida Medical Systems | 77 | 1 |
| 8.3.8.1 Deal Rationale | 77 | 1 |
| 8.3.9 Sontra Medical Merges with Echo Therapeutics | 77 | 1 |
| 8.3.9.1 Deal Rationale | 78 | 1 |
| 8.3.10 Sonomax Hearing Sells VitaSound To Trivaris | 78 | 1 |
| 8.3.10.1 Deal Rationale | 78 | 1 |
| 8.3.11 Robert Bosch Acquires Health Hero Network | 78 | 1 |
| 8.3.11.1 Deal Rationale | 78 | 1 |
| 8.3.12 Omron Healthcare Acquires Colin Medical Instruments | 78 | 1 |
| 8.3.12.1 Deal Rationale | 78 | 1 |
| 8.3.13 GE Healthcare Acquires Living Independently Group | 78 | 1 |
| 8.3.13.1 Deal Rationale | 79 | 1 |
| 8.3.14 ConvaTec Acquires Unomedical Holding | 79 | 1 |
| 8.3.14.1 Deal Rationale | 79 | 1 |
| 8.3.15 Bayer HealthCare Completes Acquisition Of iSense | 79 | 1 |
| 8.3.15.1 Deal Rationale | 79 | 1 |
| 9 Appendix | 80 | 6 |
| 9.1 Definitions | 80 | 2 |
| 9.1.1 Glucose Monitoring | 80 | 1 |
| 9.1.1.1 Blood Glucose Meters | 80 | 1 |
| 9.1.2 Insulin Delivery | 80 | 1 |
| 9.1.2.1 Insulin Pens | 80 | 1 |
| 9.1.2.2 Insulin Pumps | 80 | 1 |
| 9.1.2.3 Insulin Syringes | 80 | 1 |
| 9.1.2.4 Traditional Insulin Pump Accessories | 81 | 1 |
| 9.1.3 Inhalation Systems | 81 | 1 |
| 9.1.4 Hearing Aid Devices | 81 | 1 |
| 9.1.4.1 Analog Hearing Aids | 81 | 1 |
| 9.1.4.2 Digital Signal Processing Hearing Aids | 81 | 1 |
| 9.1.5 Patient Monitoring | 81 | 1 |
| 9.1.5.1 Non-invasive Blood Pressure Monitors | 81 | 1 |
| 9.1.5.2 Remote Patient Monitoring | 81 | 1 |
| 9.2 Acronyms | 82 | 1 |
| 9.3 Methodology | 82 | 3 |
| 9.3.1 Secondary Research | 83 | 1 |
| 9.3.2 Primary Research | 83 | 1 |
| 9.3.3 Models | 84 | 1 |
| 9.3.4 Expert Panels | 84 | 1 |
| 9.4 Contact Us | 84 | 1 |
| 9.5 Disclaimer | 85 | 1 |